CUSIP 877619106COM SHSTSHAQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
193 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Ra Capital Management, L.P. | 23.56M | $129.56M | 0 | Held |
| 2 | Avoro Capital Advisors LLC | 21.70M | $119.35M | 0 | Held |
| 3 | Blackrock, Inc. | 18.64M | $102.54M | +2.28M | Added |
| 4 | Morgan Stanley | 18.08M | $99.43M |
| −1.23M |
| Reduced |
| 5 | Rtw Investments, LP | 16.40M | $90.19M | −7.96M | Reduced |
| 6 | Vestal Point Capital, LP | 13.75M | $75.63M | +8.25M | Added |
| 7 | Goldman Sachs Group Inc | 13.69M | $75.31M | +309.0K | Added |
| 8 | Fmr LLC | 13.53M | $74.41M | −1.07M | Reduced |
| 9 | Vanguard Group Inc | 13.27M | $72.97M | +418.2K | Added |
| 10 | State Street Corp | 10.79M | $59.35M | +3.55M | Added |
See every fund holding Taysha Gene Therapies Inc, with full quarter-over-quarter share changes.
Unlock all holders